title: Do Not Use Novel Antiplatelet Agents in Patients on Oral Anticoagulants After Stenting.
authors.affiliation: Department of Cardiology, Heartcenter, Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, the Netherlands. Electronic address: f.w.a.verheugt@olvg.nl.
authors.forename: Freek W A
authors.initials: FW
authors.lastname: Verheugt
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy; D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin
keywords: aspirin; atrial fibrillation; clopidogrel; percutaneous intervention; prasugrel; ticagrelor; warfarin